| 000 | 01820 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516110419.0 | ||
| 264 | 0 | _c20131126 | |
| 008 | 201311s 0 0 eng d | ||
| 022 | _a1592-8721 | ||
| 024 | 7 |
_a10.3324/haematol.2012.069260 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWinkler, Ingrid G | |
| 245 | 0 | 0 |
_aB-lymphopoiesis is stopped by mobilizing doses of G-CSF and is rescued by overexpression of the anti-apoptotic protein Bcl2. _h[electronic resource] |
| 260 |
_bHaematologica _cMar 2013 |
||
| 300 |
_a325-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aB-Lymphocyte Subsets _xdrug effects |
| 650 | 0 | 4 | _aBenzylamines |
| 650 | 0 | 4 |
_aBone Marrow _xdrug effects |
| 650 | 0 | 4 | _aCyclams |
| 650 | 0 | 4 |
_aCyclophosphamide _xpharmacology |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadministration & dosage |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Mobilization |
| 650 | 0 | 4 |
_aHeterocyclic Compounds _xpharmacology |
| 650 | 0 | 4 |
_aLymphopoiesis _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPrecursor Cells, B-Lymphoid _xdrug effects |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
| 650 | 0 | 4 |
_aSpleen _xdrug effects |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aBendall, Linda J | |
| 700 | 1 | _aForristal, Catherine E | |
| 700 | 1 | _aHelwani, Falak | |
| 700 | 1 | _aNowlan, Bianca | |
| 700 | 1 | _aBarbier, Valerie | |
| 700 | 1 | _aShen, Yi | |
| 700 | 1 | _aCisterne, Adam | |
| 700 | 1 | _aSedger, Lisa M | |
| 700 | 1 | _aLevesque, Jean-Pierre | |
| 773 | 0 |
_tHaematologica _gvol. 98 _gno. 3 _gp. 325-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3324/haematol.2012.069260 _zAvailable from publisher's website |
| 999 |
_c22059632 _d22059632 |
||